A detailed history of Canopy Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Canopy Partners, LLC holds 1,100 shares of LLY stock, worth $980,177. This represents 0.46% of its overall portfolio holdings.

Number of Shares
1,100
Previous 1,087 1.2%
Holding current value
$980,177
Previous $846 Million 17.77%
% of portfolio
0.46%
Previous 0.41%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $9,423 - $11,817
13 Added 1.2%
1,100 $996 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $174,699 - $233,722
295 Added 37.25%
1,087 $846 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $415,950 - $490,350
792 New
792 $462 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $847B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Canopy Partners, LLC Portfolio

Follow Canopy Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canopy Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canopy Partners, LLC with notifications on news.